Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (697) 697
saids vaccines - immunology (570) 570
simian immunodeficiency virus - immunology (503) 503
macaca mulatta (411) 411
simian acquired immunodeficiency syndrome - prevention & control (388) 388
simian acquired immunodeficiency syndrome - immunology (379) 379
virology (307) 307
index medicus (288) 288
saids vaccines - administration & dosage (275) 275
immunology (262) 262
humans (260) 260
viruses (226) 226
simian immunodeficiency virus (220) 220
simian immunodeficiency virus - genetics (210) 210
rhesus macaques (195) 195
vaccination (175) 175
infection (159) 159
simian acquired immunodeficiency syndrome - virology (159) 159
female (157) 157
viral load (157) 157
cd8-positive t-lymphocytes - immunology (154) 154
vaccines (154) 154
immunization (148) 148
hiv (145) 145
virus diseases (144) 144
saids vaccines - genetics (142) 142
vaccines, dna - immunology (139) 139
aids vaccines - immunology (138) 138
immune-responses (137) 137
antibodies, viral - blood (133) 133
cd4-positive t-lymphocytes - immunology (117) 117
gene products, gag - immunology (117) 117
male (114) 114
siv (112) 112
aids (107) 107
vaccines and antiviral agents (106) 106
infectious diseases (105) 105
medicine, research & experimental (105) 105
aids vaccines (98) 98
hiv-1 - immunology (98) 98
vaccines, attenuated - immunology (98) 98
hiv infections - immunology (97) 97
animal diseases (95) 95
hiv infections - prevention & control (93) 93
vaccine (91) 91
protection (90) 90
macaques (89) 89
rhesus-monkeys (88) 88
neutralizing antibodies (86) 86
vaccines, synthetic - immunology (85) 85
article (82) 82
challenge (82) 82
t-lymphocytes, cytotoxic - immunology (82) 82
gene products, env - immunology (81) 81
genetic vectors (78) 78
replication (78) 78
vaccines, dna - administration & dosage (78) 78
t-lymphocytes - immunology (77) 77
viremia (74) 74
virus replication (74) 74
disease progression (73) 73
simian immunodeficiency virus - physiology (73) 73
antibodies, viral - immunology (72) 72
human immunodeficiency virus--hiv (70) 70
immunity, cellular (70) 70
monkeys (70) 70
hiv-1 infection (68) 68
t cells (68) 68
health aspects (67) 67
simian immunodeficiency virus - pathogenicity (67) 67
molecular sequence data (65) 65
immunization, secondary (64) 64
neutralization tests (64) 64
veterinary sciences (64) 64
disease models, animal (63) 63
gene products, gag - genetics (63) 63
in-vivo (61) 61
infections (60) 60
lymphocytes (60) 60
macaca (60) 60
aids vaccines - administration & dosage (59) 59
mice (59) 59
responses (58) 58
t-cell responses (58) 58
human-immunodeficiency-virus (57) 57
dna (55) 55
macaca mulatta - immunology (55) 55
antibodies (54) 54
cytotoxic t-lymphocytes (54) 54
hiv-1 (54) 54
antigens (51) 51
immune response (51) 51
immunity, mucosal (51) 51
lymphocyte activation (51) 51
research (49) 49
aids vaccine (48) 48
cd4 lymphocyte count (48) 48
gene products, env - genetics (48) 48
hiv-1 - genetics (48) 48
viral replication (48) 48
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
by Barouch, Dan H and Liu, Jinyan and Li, Hualin and Maxfield, Lori F and Abbink, Peter and Lynch, Diana M and Iampietro, M. Justin and Sanmiguel, Adam and Seaman, Michael S and Ferrari, Guido and Forthal, Donald N and Ourmanov, Ilnour and Hirsch, Vanessa M and Carville, Angela and Mansfield, Keith G and Stablein, Donald and Pau, Maria G and Schuitemaker, Hanneke and Sadoff, Jerald C and Billings, Erik A and Rao, Mangala and Robb, Merlin L and Kim, Jerome H and Marovich, Mary A and Goudsmit, Jaap and Michael, Nelson L
Nature, ISSN 0028-0836, 2012, Volume 482, Issue 7383, pp. 89 - 93
Preclinical studies of human immunodeficiency virus type 1 (HIV-1) vaccine candidates have typically shown post-infection virological control, but protection... 
ANTIBODIES | MEMORY | MULTIDISCIPLINARY SCIENCES | CELLULAR IMMUNE-RESPONSES | INFECTION | MACAQUES | LOW-DOSE CHALLENGE | VECTORS | BREADTH | Enzyme-Linked Immunosorbent Assay | AIDS Vaccines - immunology | Macaca mulatta - immunology | Male | Neutralization Tests | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Adenoviridae - genetics | Female | Adenoviridae - immunology | Viral Vaccines - immunology | Simian Immunodeficiency Virus - immunology | Prevention | Rhesus monkey | AIDS vaccines | Product development | Simian immunodeficiency virus | Diseases | Confidence intervals | Cytotoxicity | Immunization | Vaccines | Adenoviruses | Deoxyribonucleic acid--DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
by Barouch, Dan H and Alter, Galit and Broge, Thomas and Linde, Caitlyn and Ackerman, Margaret E and Brown, Eric P and Borducchi, Erica N and Smith, Kaitlin M and Nkolola, Joseph P and Liu, Jinyan and Shields, Jennifer and Parenteau, Lily and Whitney, James B and Abbink, Peter and Ng'ang'a, David M and Seaman, Michael S and Lavine, Christy L and Perry, James R and Li, Wenjun and Colantonio, Arnaud D and Lewis, Mark G and Chen, Bing and Wenschuh, Holger and Reimer, Ulf and Piatak, Michael and Lifson, Jeffrey D and Handley, Scott A and Virgin, Herbert W and Koutsoukos, Marguerite and Lorin, Clarisse and Voss, Gerald and Weijtens, Mo and Pau, Maria G and Schuitemaker, Hanneke
Science, ISSN 0036-8075, 07/2015, Volume 349, Issue 6245, pp. 320 - 324
Preclinical studies of viral vector-based HIV-1 vaccine candidates have previously shown partial protection against neutralization-resistant virus challenges... 
ANTIBODIES | RESPONSES | HIGHLY PATHOGENIC SIV | HIGH-THROUGHPUT | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY VIRUS-INFECTION | VECTORS | HIV-1 VACCINE | BREADTH | Gene Products, gag - immunology | Gene Products, env - immunology | Genetic Vectors - immunology | AIDS Vaccines - immunology | Histocompatibility Antigens Class I - immunology | Male | Histocompatibility Antigens Class I - genetics | Macaca mulatta | Adoptive Transfer | Adenovirus Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | Immunization, Secondary | SAIDS Vaccines - immunology | Gene Products, pol - immunology | Female | Simian Immunodeficiency Virus - immunology | Proteins | Vaccines | Monkeys & apes | Human immunodeficiency virus--HIV | Virology | Effectiveness | Mathematical analysis | Viruses | Strategy | Monkeys | Vectors (mathematics) | Protective
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
by Hansen, Scott G and Ford, Julia C and Lewis, Matthew S and Ventura, Abigail B and Hughes, Colette M and Coyne-Johnson, Lia and Whizin, Nathan and Oswald, Kelli and Shoemaker, Rebecca and Swanson, Tonya and Legasse, Alfred W and Chiuchiolo, Maria J and Parks, Christopher L and Axthelm, Michael K and Nelson, Jay A and Jarvis, Michael A and Piatak Jr, Michael and Lifson, Jeffrey D and Picker, Louis J
Nature, ISSN 0028-0836, 05/2011, Volume 473, Issue 7348, pp. 523 - 527
The acquired immunodeficiency syndrome (AIDS)-causing lentiviruses human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) effectively evade... 
CHALLENGE | MACAQUE MODEL | REPLICATION | PROTECTION | RHESUS-MONKEYS | PRIMARY HIV-1 INFECTION | IMMUNE-RESPONSES | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | AIDS | IMMUNODEFICIENCY VIRUS SIVMAC239 | Immunity, Mucosal - immunology | Vaccines, DNA - genetics | Macaca mulatta - blood | AIDS Vaccines - immunology | Macaca mulatta - immunology | Vaccines, DNA - immunology | Simian Immunodeficiency Virus - growth & development | DNA, Viral - analysis | Male | Viral Load | CD4-Positive T-Lymphocytes - immunology | Simian Immunodeficiency Virus - isolation & purification | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | Time Factors | Immunologic Memory - immunology | Simian Immunodeficiency Virus - immunology | Cytomegalovirus - genetics | Simian Immunodeficiency Virus - pathogenicity | RNA, Viral - analysis | Simian Acquired Immunodeficiency Syndrome - blood | Genetic Vectors - genetics | Simian Acquired Immunodeficiency Syndrome - prevention & control | SAIDS Vaccines - genetics | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Virus Replication | T-Lymphocytes - immunology | CD8-Positive T-Lymphocytes - immunology | Plasma | Immunization | Acquired immune deficiency syndrome--AIDS | Pathogenesis | Human immunodeficiency virus--HIV | Deoxyribonucleic acid--DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Vaccine-induced CD8+ T cells control AIDS virus replication
by Mudd, Philip A and Martins, Mauricio A and Ericsen, Adam J and Tully, Damien C and Power, Karen A and Bean, Alex T and Piaskowski, Shari M and Duan, Lijie and Seese, Aaron and Gladden, Adrianne D and Weisgrau, Kim L and Furlott, Jessica R and Kim, Young-Il and De Santana, Marlon G. Veloso and Rakasz, Eva and Iii, Saverio Capuano and Wilson, Nancy A and Bonaldo, Myrna C and Galler, Ricardo and Allison, David B and Piatak Jr, Michael and Haase, Ashley T and Lifson, Jeffrey D and Allen, Todd M and Watkins, David I
Nature, ISSN 0028-0836, 11/2012, Volume 491, Issue 7422, pp. 129 - 133
Developing a vaccine for human immunodeficiency virus(HIV) may be aided by a complete understanding of those rare cases in which some HIV-infected individuals... 
SIV | RESPONSES | CHALLENGE | HIV | DETERMINANTS | MULTIDISCIPLINARY SCIENCES | DISEASE | MAMU-B-ASTERISK-08-POSITIVE MACAQUES | IMMUNODEFICIENCY | ESCAPE | RHESUS MACAQUES | Immunodominant Epitopes - immunology | Humans | AIDS Vaccines - immunology | Macaca mulatta - immunology | Simian Immunodeficiency Virus - growth & development | Male | Viral Load | Macaca mulatta - virology | Simian Acquired Immunodeficiency Syndrome - virology | Female | HLA-B27 Antigen - immunology | Epitopes, T-Lymphocyte - immunology | Acquired Immunodeficiency Syndrome - virology | Disease Models, Animal | Simian Immunodeficiency Virus - immunology | Simian Immunodeficiency Virus - pathogenicity | Virus Replication - immunology | Simian Acquired Immunodeficiency Syndrome - prevention & control | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Viremia - prevention & control | Viremia - immunology | CD8-Positive T-Lymphocytes - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text HIV vaccines
by McMichael, Andrew J
Annual Review of Immunology, ISSN 0732-0582, 2006, Volume 24, Issue 1, pp. 227 - 255
A prophylactic vaccine for HIV-1 is badly needed. Despite 20 years it is still a long way off. However, considerable progress has of effort, been made in... 
HIV-1 | T cell immunity | Vaccination | Neutralizing antibody | GP120 ENVELOPE GLYCOPROTEIN | neutralizing antibody | THERAPEUTIC IMMUNIZATION | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 ANTIBODY 2F5 | DNA-BASED VACCINE | PLASMACYTOID DENDRITIC CELLS | T-CELL RESPONSES | IMMUNE-RESPONSES | vaccination | ACUTE INFECTION | HIV Infections - prevention & control | AIDS Vaccines - pharmacology | Humans | AIDS Vaccines - immunology | Neutralization Tests | Clinical Trials as Topic | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV-1 - immunology | Models, Immunological | SAIDS Vaccines - pharmacology | Animals | SAIDS Vaccines - immunology | HIV Infections - therapy | Macaca
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
by Roederer, Mario and Keele, Brandon F and Schmidt, Stephen D and Mason, Rosemarie D and Welles, Hugh C and Fischer, Will and Labranche, Celia and Foulds, Kathryn E and Louder, Mark K and Yang, Zhi-Yong and Todd, John-Paul M and Buzby, Adam P and Mach, Linh V and Shen, Ling and Seaton, Kelly E and Ward, Brandy M and Bailer, Robert T and Gottardo, Raphael and Gu, Wenjuan and Ferrari, Guido and Alam, S. Munir and Denny, Thomas N and Montefiori, David C and Tomaras, Georgia D and Korber, Bette T and Nason, Martha C and Seder, Robert A and Koup, Richard A and Letvin, Norman L and Rao, Srinivas S and Nabel, Gary J and Mascola, John R
Nature, ISSN 0028-0836, 2014, Volume 505, Issue 7484, pp. 502 - 508
A major challenge for the development of a highly effective AIDS vaccine is the identification of mechanisms of protective immunity. To address this question,... 
NEUTRALIZING ANTIBODIES | CELL RESPONSES | SIMIAN IMMUNODEFICIENCY VIRUS | EFFICACY TRIAL | MULTIDISCIPLINARY SCIENCES | SIVSME660 | PREVENTION | INFECTION | DOSE CHALLENGE EXPERIMENTS | BINDING | RHESUS MACAQUES | HIV Infections - prevention & control | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Male | Risk | Macaca mulatta | Phylogeny | Simian Immunodeficiency Virus - chemistry | Founder Effect | HIV Infections - immunology | Antibodies, Neutralizing - immunology | Simian Acquired Immunodeficiency Syndrome - virology | Simian Immunodeficiency Virus - genetics | Disease Susceptibility - immunology | HIV Antibodies - immunology | HIV-1 - chemistry | Female | Simian Immunodeficiency Virus - immunology | Amino Acid Sequence | HIV Infections - virology | Simian Immunodeficiency Virus - physiology | Simian Acquired Immunodeficiency Syndrome - prevention & control | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Immune Evasion - immunology | Antigen-antibody reactions | AIDS vaccines | Immune complexes | AIDS (Disease) | Monoclonal antibodies | Physiological aspects | Research | AIDS research | Health aspects | Viruses | Vaccines | Laboratory animals | Cloning | Human immunodeficiency virus--HIV | Deoxyribonucleic acid--DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
by Chen, Minchun and Guan, Liming and Evans, Robert K and Dubey, Sheri A and Handt, Larry and Miura, Ayako and Liang, Xiaoping and Youil, Rima and Grimm, Karen M and Volkin, David B and Huang, Lingyi and Emini, Emilio A and Fernandez, V. Rose and Xu, Zheng and Punt, Kara S and Bohannon, Kathryn E and Kaslow, David C and Persaud, Natasha V and Zhu, Lan and Joyce, Joseph G and Troutman, Robert D and Isopi, Lynne A and Heidecker, Gwendolyn J and Davies, Mary-Ellen and Krivulka, Georgia R and Lifton, Michelle A and Tang, Aimin and Bett, Andrew J and Shiver, John W and Perry, Helen C and Freed, Daniel C and Schmitz, Jörn E and Chen, Ling and Simon, Adam J and Caulfield, Michael J and Fu, Tong-Ming and Letvin, Norman L and Kresock, Denise S and Schleif, William A and Wilson, Keith A and Trigona, Wendy L and Collins, Kelly B and Harris, Virginia A and Williams, Donna M and Zhang, Zhi-Qiang and Keller, Paul M and Cook, James C and Kuroda, Marcelo J and Montefiori, David C and Long, Romnie S and Casimiro, Danilo R and Mach, Henryk
Nature, ISSN 0028-0836, 01/2002, Volume 415, Issue 6869, pp. 331 - 335
Recent studies of human immunodeficiency virus type 1 (HIV-1) infection in humans and of simian immunodeficiency virus (SIV) in rhesus monkeys have shown that... 
INFECTED RHESUS-MONKEYS | RESPONSES | VIREMIA | MULTIDISCIPLINARY SCIENCES | DOMINANT | MAMU-A-ASTERISK-01 | TYPE-1 INFECTION | CYTOTOXIC T-LYMPHOCYTES | DNA VACCINATION | DISEASE PROGRESSION | EPITOPES | HIV Infections - prevention & control | AIDS Vaccines - immunology | Macaca mulatta | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Simian Immunodeficiency Virus - genetics | Adenoviridae - immunology | Simian Immunodeficiency Virus - immunology | Gene Products, gag - immunology | Gene Products, gag - genetics | Genetic Vectors - immunology | SAIDS Vaccines - administration & dosage | Vaccines, Synthetic - genetics | Defective Viruses - genetics | Adenoviridae - physiology | HIV-1 - genetics | Genetic Vectors - genetics | Simian Acquired Immunodeficiency Syndrome - prevention & control | SAIDS Vaccines - genetics | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Virus Replication | AIDS Vaccines - genetics | Antibodies, Viral - immunology | Defective Viruses - immunology | AIDS Vaccines - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Human immunodeficiency virus | Vaccines | HIV | Monkeys & apes | Deoxyribonucleic acid | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
by Dennis R. Burton and Ann J. Hessell and Brandon F. Keele and Per Johan Klasse and Thomas A. Ketas and Brian Moldt and D. Cameron Dunlop and Pascal Poignard and Lara A. Doyle and Lisa Cavacini and Ronald S. Veazey and John P. Moore
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2011, Volume 108, Issue 27, pp. 11181 - 11186
To guide vaccine design, we assessed whether human monoclonal antibodies (MAbs) b12 and b6 against the CD4 binding site (CD4bs) on HIV-1 gp120 and F240 against... 
Shivs | Neutralizing antibodies | Vaccination | Virions | Antibodies | Viruses | Infections | Epitopes | Dosage | HIV 1 | Passive immunization | Binding antibodies | HIV VACCINES | MULTIDISCIPLINARY SCIENCES | HUMAN MONOCLONAL-ANTIBODY | ENVELOPE GLYCOPROTEIN | binding antibodies | IN-VITRO | TRANSMISSION | IMMUNODEFICIENCY-VIRUS TYPE-1 | passive immunization | INFECTION | MONKEYS | BINDING | RHESUS MACAQUES | Antibodies, Neutralizing - administration & dosage | HIV Infections - prevention & control | HIV Envelope Protein gp41 - immunology | Humans | AIDS Vaccines - immunology | Vagina - immunology | Molecular Sequence Data | Macaca mulatta | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | Simian Immunodeficiency Virus - genetics | Female | Membrane Glycoproteins - immunology | Simian Immunodeficiency Virus - immunology | SAIDS Vaccines - administration & dosage | HIV-1 - genetics | HIV Antibodies - administration & dosage | Simian Acquired Immunodeficiency Syndrome - prevention & control | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Monoclonal - administration & dosage | Vagina - virology | Immunization, Passive | Viral Envelope Proteins - immunology | AIDS Vaccines - administration & dosage | Monoclonal antibodies | Physiological aspects | Vaginal diseases | Genetic aspects | HIV (Viruses) | Health aspects | Vaccines | Monkeys & apes | Human immunodeficiency virus--HIV | Binding sites | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
by Gautam, Rajeev and Nishimura, Yoshiaki and Pegu, Amarendra and Nason, Martha C and Klein, Florian and Gazumyan, Anna and Golijanin, Jovana and Buckler-White, Alicia and Sadjadpour, Reza and Wang, Keyun and Mankoff, Zachary and Schmidt, Stephen D and Lifson, Jeffrey D and Mascola, John R and Nussenzweig, Michel C and Martin, Malcolm A
Nature, ISSN 0028-0836, 05/2016, Volume 533, Issue 7601, pp. 105 - 109
Despite the success of potent anti-retroviral drugs in controlling human immunodeficiency virus type 1 (HIV-1) infection, little progress has been made in... 
SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS | POTENT | TRANSMISSION | HIV-1/SIV CHIMERIC VIRUS | BROADLY NEUTRALIZING ANTIBODY | MULTIDISCIPLINARY SCIENCES | IMPROVES PROTECTION | PASSIVE TRANSFER | MACAQUES | INFECTION | MONOCLONAL-ANTIBODIES | HIV Antibodies - blood | Antibodies, Neutralizing - administration & dosage | HIV Infections - prevention & control | AIDS Vaccines - immunology | Macaca mulatta - immunology | Half-Life | Male | Antibodies, Monoclonal - blood | HIV Infections - immunology | Macaca mulatta - virology | Antibodies, Neutralizing - immunology | Immunoglobulin Fc Fragments - immunology | HIV Antibodies - immunology | Time Factors | Female | HIV Infections - transmission | Antibodies, Monoclonal - immunology | Simian Immunodeficiency Virus - immunology | Protein Structure, Tertiary | SAIDS Vaccines - administration & dosage | Immunoglobulin Fc Fragments - chemistry | Antibodies, Neutralizing - genetics | Mutation - genetics | Simian Acquired Immunodeficiency Syndrome - blood | HIV Antibodies - administration & dosage | Simian Acquired Immunodeficiency Syndrome - prevention & control | Antibodies, Monoclonal - genetics | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Monoclonal - administration & dosage | HIV Antibodies - genetics | AIDS Vaccines - administration & dosage | Immunoglobulin Fc Fragments - genetics | Antibodies, Neutralizing - blood | Prevention | Viral antibodies | Antibodies | Dosage and administration | HIV infection | Patient outcomes | Monoclonal antibodies | Immunoglobulins | Immunization | Vaccines | Human immunodeficiency virus--HIV | Viral infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
by Rama Rao Amara and Francois Villinger and John D. Altman and Shari L. Lydy and Shawn P. O'Neil and Silvija I. Staprans and David C. Montefiori and Yan Xu and James G. Herndon and Linda S. Wyatt and Maria Angelito Candido and Natalia L. Kozyr and Patricia L. Earl and James M. Smith and Hak-Ling Ma and Bennett D. Grimm and Michael L. Hulsey and Joseph Miller and Harold M. McClure and Janet M. McNicholl and Bernard Moss and Harriet L. Robinson
Science, ISSN 0036-8075, 4/2001, Volume 292, Issue 5514, pp. 69 - 74
Heterologous prime/boost regimens have the potential for raising high levels of immune responses. Here we report that DNA priming followed by a recombinant... 
T lymphocytes | Shivs | RNA | Geometric mean | DNA | Vaccination | Antibodies | Viruses | Viral RNA | Lymph nodes | Research Article | RESPONSES | NEUTRALIZING ANTIBODIES | REPLICATION | ASSAY | RHESUS-MONKEYS | ENVELOPE GLYCOPROTEINS | MULTIDISCIPLINARY SCIENCES | INFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | PATHOGENIC SIV | HIV Antibodies - blood | Germinal Center - immunology | AIDS Vaccines - immunology | Immunity, Mucosal | Vaccines, DNA - immunology | Macaca mulatta | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Vaccines, DNA - administration & dosage | Vaccinia virus - immunology | Viral Load | CD4-Positive T-Lymphocytes - immunology | Acquired Immunodeficiency Syndrome - immunology | Simian Acquired Immunodeficiency Syndrome - virology | Simian Immunodeficiency Virus - genetics | HIV-1 - physiology | Immunization, Secondary | HIV Antibodies - immunology | Acquired Immunodeficiency Syndrome - virology | Simian Immunodeficiency Virus - immunology | SAIDS Vaccines - administration & dosage | Acquired Immunodeficiency Syndrome - prevention & control | Lymph Nodes - immunology | HIV-1 - genetics | Simian Immunodeficiency Virus - physiology | Simian Acquired Immunodeficiency Syndrome - prevention & control | HIV-1 - immunology | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Viral - immunology | Immunologic Memory | T-Lymphocytes - immunology | Vaccines, Synthetic - administration & dosage | AIDS Vaccines - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Interferon-gamma - biosynthesis | Cellular immunity | Immunodeficiency | Research | Proteins | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | Vaccines | Monkeys & apes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge
by Kwa, Suefen and Kwa, Suefen and Lai, Lilin and Lai, Lilin and Gangadhara, Sailaja and Gangadhara, Sailaja and Siddiqui, Mariam and Siddiqui, Mariam and Pillai, Vinod B and Pillai, Vinod B and Labranche, Celia and Labranche, Celia and Yu, Tianwei and Yu, Tianwei and Moss, Bernard and Moss, Bernard and Montefiori, David C and Montefiori, David C and Robinson, Harriet L and Robinson, Harriet L and Kozlowski, Pamela A and Kozlowski, Pamela A and Amara, Rama Rao and Amara, Rama R.ao
Journal of virology, ISSN 0022-538X, 2014, Volume 88, Issue 17, pp. 9579 - 9589
It remains a challenge to develop a successful human immunodeficiency virus (HIV) vaccine that is capable of preventing infection. Here, we utilized the... 
CD154 | VIROLOGY | COLONY-STIMULATING FACTOR | IN-VIVO | ACQUISITION | EXPRESSING CD40 LIGAND | DNA VACCINATION | DNA/MVA VACCINE | T-LYMPHOCYTES | RHESUS MACAQUES | CUTTING EDGE | Vaccines, DNA - genetics | Adjuvants, Immunologic - administration & dosage | CD40 Ligand - administration & dosage | Immunity, Mucosal | Vaccines, DNA - immunology | Drug Carriers - administration & dosage | Macaca mulatta | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Vaccines, DNA - administration & dosage | Vaccinia virus - genetics | CD4-Positive T-Lymphocytes - immunology | Simian Immunodeficiency Virus - genetics | Vaccines, Virus-Like Particle - genetics | Vaccination - methods | Adjuvants, Immunologic - genetics | Simian Immunodeficiency Virus - immunology | SAIDS Vaccines - administration & dosage | Vaccines, Synthetic - genetics | Simian Acquired Immunodeficiency Syndrome - prevention & control | SAIDS Vaccines - genetics | Vaccines, Virus-Like Particle - administration & dosage | Animals | SAIDS Vaccines - immunology | CD40 Ligand - genetics | Simian Acquired Immunodeficiency Syndrome - immunology | Vaccines, Virus-Like Particle - immunology | Vaccines, Synthetic - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Immunity, Cellular | Vaccines and Antiviral Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights